Sabatino Susan A, White Mary C, Thompson Trevor D, Klabunde Carrie N
MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):464-8.
Regular breast, cervical, and colorectal cancer (CRC) screening with timely and appropriate follow-up and treatment reduces deaths from these cancers. Healthy People 2020 targets for cancer screening test use have been established, based on the most recent U.S. Preventive Services Task Force (USPSTF) guidelines. National Health Interview Survey (NHIS) data are used to monitor progress toward the targets. CDC used the 2013 NHIS, the most recent data available, to examine breast, cervical, and CRC screening use. Although some demographic subgroups attained targets, screening use overall was below the targets with no improvements from 2010 to 2013 in breast, cervical, or CRC screening use. Cervical cancer screening declined from 2010 to 2013. Increased efforts are needed to achieve targets and reduce screening disparities.
定期进行乳腺癌、宫颈癌和结直肠癌（CRC）筛查，并及时进行适当的后续跟进和治疗，可降低这些癌症导致的死亡人数。基于美国预防服务工作组（USPSTF）的最新指南，已制定了《健康人民2020》中癌症筛查检测使用的目标。国家健康访谈调查（NHIS）数据用于监测朝着这些目标取得的进展。美国疾病控制与预防中心（CDC）利用2013年的NHIS（可获取的最新数据）来检查乳腺癌、宫颈癌和结直肠癌筛查的使用情况。尽管一些人口亚组达到了目标，但总体筛查使用率低于目标，2010年至2013年期间乳腺癌、宫颈癌或结直肠癌筛查使用率没有改善。2010年至2013年期间宫颈癌筛查率有所下降。需要加大努力以实现目标并减少筛查差距。
